Busting the myth that pen-and-paper is better than electronic outcome assessments
Clinical outcome assessments administered with pen-and-paper tasks have long been the assessment method of choice for measuring treatment effects on patients. However, with the advent of electronic alternatives - how do these two assessment methods compare?
Cambridge Cognition signs new eCOA contracts
Cambridge Cognition today announced it has won a significant new phase IV clinical trial contract for use of its electronic clinical outcomes assessment (eCOA) platform, CANTAB Connect.
web-based testing, wearables, voice, virtual clinical trials, technology, swm, subjective measures, stigma, social cognition, smartphones, sleep, schizophrenia research, schizophrenia, safety, rvp, rti, research funding, research, remote testing, regulations, recruitment, rare disease, prodromal, pro-cognitive, prm, press release, presenteeism, precision psychiatry, pre-clinical, poster, personalised medicine, patient-centric, patient recruitment, parkinson's disease, pal, paired associates learning, ots, occupational health, normative data, neuroscience, near-patient testing, multiple sclerosis, mts, ms, modelling, mental wellbeing, mdd, mci, major depression, machine learning, life at cambridge cognition, high-frequency testing, healthcare, grant, funding, fatigue, ert, epidemiology, ebt, early career researchers, early alzheimer's disease, drug development, dms, digital tools, digital health, depression, dementia, covid-19, cognitive testing, cognitive science, cognitive safety, cognitive impairment, cognitive function, cognitive dysfunction, cognitive deficits, cognitive biomarkers, cognitive assessment, cognition kit, cognition, cns summit, clinical trials, clinical trial, cias, chronic illness, chronic health conditions, cgt, cantab testimonial, cantab research grant, cantab, cambridge cognition careers, cambridge cognition, brain health, biomarkers, automatic speech recognition, autism, attention, asr, alzheimer's disease, academic, absenteeism,